Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

Everhope Oncology Launches First Cancer Daycare Centre in Gurugram -- Revolutionizing Cancer Care with Compassion, Precision and Convenience


News provided by

Everhope Oncology

06 Aug, 2025, 12:52 IST

Share this article

Share toX

Share this article

Share toX

Everhope Oncology takes the anxiety out of cancer treatment — with zero wait time, 2X faster service, pre-booked diagnostics, and personalised concierge-led assistance.

GURUGRAM, India, Aug. 6, 2025 /PRNewswire/ -- Everhope Oncology, a next-generation cancer care platform backed by Narayana Health, W Health Ventures, and 2070 Health, today announced the launch of its first 15-bed dedicated cancer daycare centre in Sector 65, Gurugram. Situated strategically on Golf Course Extension Road, this state-of-the-art facility transforms how cancer care is delivered in India — especially for cancer patients who desire seamless, personalized treatment without compromising their quality of life. Everhope provides clinical excellence in a non-hospital, healing-led environment. More than a facility, Everhope is a bold movement to redefine cancer care — from fear and confusion to clarity, convenience, and dignity.

"This is not just a launch of another healthcare facility. It's a response to what millions of Indian patients need — accessible, dignified cancer care that doesn't uproot their entire lives," said Gaurav Porwal, Director, Everhope Oncology. "We are solving India's cancer care gaps by reimagining the entire experience — from long queues and hospital overwhelm to a centre that's calm, close to home, and clinically world-class. Our daycare model eliminates the logistical and emotional barriers that often delay or complicate treatment. Patients can receive their chemotherapy in the morning and return to their normal activities by afternoon. And, what also sets us apart is our focus on personalized nutrition guidance from functional medicine experts, tailored to each patient's unique needs. This expert support not only aids recovery but also helps optimize treatment outcomes — ensuring that every patient receives holistic care, not just medical intervention. With the demand for 40,000 new cancer beds projected in India over the next few years, we believe the Everhope model is timely, viable, and scalable."

Cancer care is evolving — globally and in India. While earlier, treatments required long hospital stays and multiple visits to distant tertiary centres, the daycare model is now considered the gold standard in high-income countries. Over 60% of chemotherapy and immunotherapy sessions worldwide are delivered via daycare — enabling patients to recover at home, maintain routine, and reduce exposure to hospital-borne infections.

India, however, faces a growing cancer burden — with 8 million+ active cases, and 1 in 9 Indians projected to develop cancer in their lifetime. Coupled with a doctor-patient ratio of 1 oncologist for every 2,000 patients, delays in diagnosis and treatment are common. Everhope bridges this critical gap by bringing precision oncology closer to the patient, while reducing logistical stress and psychological barriers.

"Our clinical offering isn't just comprehensive — it's cohesive," said Dr. Sunny Garg, Chief Medical Officer, Everhope Oncology. "With a high-powered Tumor Board, protocol adherence, and patient tracking systems, we ensure every treatment is tailored, evidence-backed, and emotionally intelligent. Whether it's immunotherapy, palliative care, or integrative support — we aim to deliver world-class outcomes centred around the patients in a neighbourhood setting. Cancer patients shouldn't have to choose between world-class treatment and maintaining their quality of life. Our daycare model recognizes that these patients want to continue working, spending time with family, and sleeping in their own beds. Research shows that outpatient chemotherapy not only maintains equivalent clinical outcomes but often improves patient satisfaction and psychological well-being."

Everhope Oncology raised $10 million in seed funding, making it one of the largest early-stage investments in Indian healthcare in recent years. The joint venture brings together clinical excellence from Narayana Health, venture innovation from W Health, and GTM and Technology capabilities from 2070 Health. After the successful launch of the Gurugram centre, Everhope plans to open additional centres across NCR, including South Delhi and Noida in the coming months. The brand is also finalising locations in Mumbai and Bangalore, with a 10-city expansion roadmap planned over the next three years. With a mission to deliver 100,000+ cancer sessions over the next 36 months, Everhope is poised to reshape how India treats, manages, and overcomes cancer — with dignity, speed, and strength.

Everhope's unique edge

  • 15-bed private suites designed for chemotherapy and targeted therapy
  • 24x7 patient concierge support for appointment management and care continuity
  • 2x time saving at every stage from diagnostics to therapy, during consultation, billing and also parking
  • On-demand diagnostics with pre-booked lab & imaging services
  • Financial assistance cell for insurance, EMIs, and cost transparency
  • A Super Specialist Tumor Board of oncologists across medical, surgical, and radiation specialties
  • Precision Oncology Pathways with protocol-driven care and clinical audits
  • Mental health Emotional support and counselling for patients and next of kin
  • Customised Nutrition: Patients receive tailored meal plans designed by onco-nutrition experts to aid recovery and boost immunity

About Everhope Oncology:

Everhope is India's first specialised cancer daycare brand committed to transforming how cancer care is experienced and delivered. It's focused on delivering holistic, localised, and emotionally intelligent oncology care. From chemotherapy to counselling, diagnostics to diet, Everhope builds a 360-degree support ecosystem — centred entirely around the patient.

Everhope Oncology is India's first patient-first, technology-enabled cancer daycare platform committed to transforming how cancer care is experienced and delivered. Founded in 2025 as a joint venture between Narayana Health, W Health Ventures, and 2070 Health, Everhope focuses on delivering high-quality, decentralised cancer treatment through accessible, emotionally intelligent, and clinically robust facilities.

Each Everhope centre is designed to offer same-day chemotherapy, immunotherapy, diagnostics, nutrition, mental health counselling, and concierge support — all under one roof. With zero wait times, expert-led tumor boards, and integrated care pathways, Everhope aims to reduce the logistical, financial, and emotional burdens typically associated with cancer treatment.

The brand's vision is to expand across 10 cities in the next three years, bringing compassionate, world-class oncology care closer to where people live and work.

For more information, visit: https://everhope.care/

Media Contact:
Garima Nijhawan I +91-9899175275
Sonia Kamboj I +91-9811227979
[email protected]
[email protected]

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.